Form D · Biotechnology
Balance Therapeutics, Inc.
San Bruno, CA · CIK 0001636982
Offering snapshot reported May 19, 2015 · SEC filing
- Reported sold
- $183K Offering amount: $183K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 6, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 19, 2015 | Initial | $183,106 | No comparison | 1 | SEC filing |
| May 5, 2015 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Mar 19, 2015 | Initial | $17,982,388 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240194
Exact amount of second subsequent closing $183,106.01
Source: Form D, filed May 19, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Carlton | Director |
| Richard Chin | Director |
| Michael Grey | Director |
| Lyndon Lien | Director, Executive |
| Phyllis E. Whiteley | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1250 Bayhill Drive Suite 125
San Bruno, CA, 94066
San Bruno, CA, 94066